Schedule

This session will explore the role of circulating biomarkers in prenatal health and infectious disease, highlighting advances in detection, monitoring, and insights into maternal and fetal biology.

This session will focus on technological advances in cfDNA analysis, including sequencing strategies, bioinformatics approaches, and innovations that improve sensitivity, specificity, and scalability.

This session will address the challenges and opportunities involved in translating cfDNA technologies into clinical practice, including validation, standardization, regulatory considerations, and real-world implementation.